Route labels hide different scientific barriers

Peptides can face enzymatic degradation, low membrane permeability, mucosal clearance, skin-barrier limitations or local compatibility constraints. A route mentioned in literature does not establish that a raw research material is suitable for that route or for human use.

Formulation evidence is route-specific

Parenteral, oral, buccal or sublingual, intranasal and topical research each raises different questions about excipients, pH, osmolality, sterility, preservatives, stability, delivery devices and analytical controls. Study design should follow an approved institutional protocol.

  • Research model and route-specific endpoint
  • Formulation compatibility and stability
  • Device or container interaction
  • Analytical recovery and concentration basis
  • Institutional safety and ethics controls

Keep research context separate from instructions

LyoPep public products are for laboratory Research Use Only. The website explains scientific and procurement concepts but does not provide personal dosing, injection, administration or reconstitution directions.

Primary references

ICH Q8(R2) Pharmaceutical Development